Artículos por temáticas

Functional eye movement disorders.

Kaski D, Bronstein AM.

Handb Clin Neurol. 2017;139:343-351. doi: 10.1016/B978-0-12-801772-2.00030-8.

[Functional neurological movement disorders].

Søborg PA, Albrechtsen L, Olsen HH, laCour P.

Ugeskr Laeger. 2017 Dec 11;179(50). pii: V04170295. Danish.

Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.

Milosevic L, Kalia SK, Hodaie M, Lozano AM, Fasano A, Popovic MR, Hutchison WD.

Brain. 2017 Dec 11. doi: 10.1093/brain/awx296. [Epub ahead of print]

Autophagy impairment in Parkinson's disease.

Karabiyik C, Lee MJ, Rubinsztein DC.

Essays Biochem. 2017 Dec 12;61(6):711-720. doi: 10.1042/EBC20170023. Print 2017 Dec 12. Review.

Effects of cerebellar neuromodulation in movement disorders: A systematic review.

França C, de Andrade DC, Teixeira MJ, Galhardoni R, Silva V, Barbosa ER, Cury RG.

Brain Stimul. 2017 Nov 23. pii: S1935-861X(17)30971-3. doi: 10.1016/j.brs.2017.11.015. [Epub ahead of print] Review.

Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.

An C, Pu X, Xiao W, Zhang H.

Neurosci Lett. 2017 Dec 11;665:236-239. doi: 10.1016/j.neulet.2017.12.023. [Epub ahead of print]

Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.

Yue P, Gao L, Wang X, Ding X, Teng J.

J Cell Biochem. 2017 Dec 14. doi: 10.1002/jcb.26608. [Epub ahead of print]

ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.

Subramaniam RM, Frey KA, Hunt CH, Mercier GA Jr, Solnes LB, Colletti PM, Lu Y, Savir-Baruch B, Williams HT.

Clin Nucl Med. 2017 Sep 15. doi: 10.1097/RLU.0000000000001815. [Epub ahead of print]

Novel Parkinson's disease risk loci identified through a meta-analysis of genome-wide association studies.

Liu Z, Tang B.

Mov Disord. 2017 Dec 21. doi: 10.1002/mds.27276. [Epub ahead of print] No abstract available.

Altered emotional prosody processing in patients with Parkinson's disease after subthalamic nucleus stimulation.

Jin Y, Mao Z, Ling Z, Xu X, Xie G, Yu X.

Neuropsychiatr Dis Treat. 2017 Dec 11;13:2965-2975. doi: 10.2147/NDT.S153505. eCollection 2017.

Functional movement disorders.

Barbey A, Aybek S.

Curr Opin Neurol. 2017 Aug;30(4):427-434. doi: 10.1097/WCO.0000000000000464.

The effect of istradefylline for Parkinson's disease: A meta-analysis.

Sako W, Murakami N, Motohama K, Izumi Y, Kaji R.

Sci Rep. 2017 Dec 21;7(1):18018. doi: 10.1038/s41598-017-18339-1.

Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.

Nackaerts E, Broeder S, Pereira MP, Swinnen SP, Vandenberghe W, Nieuwboer A, Heremans E.

PLoS One. 2017 Dec 22;12(12):e0190223. doi: 10.1371/journal.pone.0190223. eCollection 2017.

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2017 May;32(5):724-725. doi: 10.1002/mds.27045. No abstract available.

Comment: β-Amyloid pathology and Parkinson disease.

Dodel R.

Neurology. 2017 Dec 5;89(23):2339. doi: 10.1212/WNL.0000000000004756. Epub 2017 Nov 8. No abstract available.